Live Quote · NASDAQSLSHealthcare· Biotechnology

SELLAS Life Sciences Group, Inc.

$13.66▼ 8.08%($-1.20)
MKT CAP $2.78BNEXT EARNINGS Mar 25, 2027
50%
Bullish
TickerSpark Score
59/100
▌ Mixed
30
Valuation
20
Profitability
60
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SLS research report →

Analyst Price Target
$35.00+156.2% vs. today

Range $35 – $35

Analyst RatingBuy
5 Buy0 Hold0 Sell

Price Chart

+835.62% · this period
$19.15$10.27$1.39Nov 20May 26Nov 20
52-Week Range52% of range
Low
$1.39
Current
$13.66
High
$24.89